Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Cost of Revenue (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Cost of Revenue over the past 16 years, most recently at $22.5 million for Q2 2025.

  • For Q2 2025, Cost of Revenue rose 8.96% year-over-year to $22.5 million; the TTM value through May 2025 reached $88.6 million, up 2.5%, while the annual FY2025 figure was $88.6 million, 2.5% up from the prior year.
  • Cost of Revenue for Q2 2025 was $22.5 million at Lifecore Biomedical, Inc. \De\, down from $25.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $25.3 million in Q1 2025 and troughed at -$30.1 million in Q2 2021.
  • A 5-year average of $16.9 million and a median of $19.8 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: tumbled 87.3% in 2021 and later surged 140.0% in 2022.
  • Year by year, Cost of Revenue stood at $14.1 million in 2021, then increased by 14.44% to $16.2 million in 2022, then grew by 24.76% to $20.2 million in 2023, then grew by 6.37% to $21.5 million in 2024, then grew by 4.57% to $22.5 million in 2025.
  • Business Quant data shows Cost of Revenue for LFCR at $22.5 million in Q2 2025, $25.3 million in Q1 2025, and $21.5 million in Q4 2024.